CVS Health has launched a big new program to help make fertility treatments more affordable and easier to get for people all over the United States. This effort involves expanding services through CVS Specialty Pharmacy and offering easy pick-up options at more than 9,000 CVS Pharmacy locations across the country. With this move, CVS is entering an important area of healthcare by teaming up with the TrumpRx Fertility program, which is part of the Trump Administration’s larger plan to lower the cost of necessary medicines. One main part of this program is reducing the cost of Gonal-F, a widely used fertility drug in IVF, by 84 percent through a partnership with its maker, EMD Serono.
Health Technology Insights: Humana’s 2026 Medicare Advantage Plans Focus on Quality Care
CVS Specialty Pharmacy is a central part of this program and has specific knowledge about fertility medications. Their team of trained pharmacists helps individuals manage treatment plans safely and offers advice on dealing with insurance benefits and financial options. By linking patients with these resources, CVS aims to make a process that is often stressful and time-sensitive easier to handle. The company says working closely with doctors, insurers, and families from the start helps people move forward with treatment more quickly and with more confidence.
Health Technology Insights: InteropKey and Corista Unite for Value-Based Care Growth
Lucille Accetta, RPh, who is the Senior Vice President and Chief Pharmacy Officer at CVS Health, said the goal is to simplify the experience for families going through fertility treatment. She pointed out that these medicines need special handling and patient support, and CVS is well-equipped to provide both. She mentioned that CVS is proud to join the President’s initiative to make fertility care more accessible and affordable by offering wide-ranging pharmacy support and expert guidance. She added that CVS has the right mix of clinical knowledge, convenient access, and cost-saving solutions to help meet the goals of the TrumpRx Fertility platform.
The TrumpRx Fertility program is expected to officially start in January 2026. CVS confirmed that Gonal-F will be one of the medications offered at a lower cost, though more medications and manufacturers may be added as the launch date gets closer. The program is especially helpful for people undergoing fertility treatments like IVF, where timing and quick access to medicines are essential. By providing a fixed, competitive price and making the pharmacy experience simpler, CVS hopes to eliminate the need for patients to search through multiple providers for prescriptions.
CVS Specialty Pharmacy will continue to support patients in key ways. Services include free pre-verification of insurance benefits to help patients and doctors find the most affordable options, help with insurance claims, and assistance in finding financial help if fertility drugs are not covered by a health plan. Patients get personalized advice from a team of pharmacists trained in fertility medications. These experts can answer questions, guide on how to use the drugs correctly, help with injections, and assist with managing side effects throughout treatment. In cases where donor egg therapy is used, they also help coordinate the medication needs specific to that process. What makes CVS different from many other specialty pharmacies is its flexibility. Patients can choose to pick up their medications at any CVS Pharmacy location or have them delivered directly to their home, doctor’s office, or even a temporary address. All deliveries are in secure, temperature-controlled packaging, and next-day delivery is available at no extra cost. With this new fertility initiative, CVS Health is expanding its role in making personalized healthcare more accessible and continuing its focus on reducing drug costs and improving convenience for people managing complex medical needs.
Health Technology Insights: Pharmanovia Appoints Stephan Eder as Chief Executive Officer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
